- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
Measurable Residual Disease-Guided Therapy Promising in CLL -
AlertFDA Approves Pirtobrutinib for Previously Treated CLL/SLL -
'Promising' New Txs for Most Common Adult Leukemia -
BTKi Combo Strong Option in CLL
-
Promising Early Data: Pirtobrutinib in Hard-to-Treat CLL/SLL
-
Take 2: CMS Launches Successor to the Oncology Care Model
-
EHA 2023CLL: Venetoclax-Obinutuzumab Combo Effective Long Term
-
ASCO 2023'Remarkable': CAR T Therapy for CLL/SLL
Perspective View All
Journal Articles View All
-
Isolated Ocular Mpox Without Skin Lesions, United States
-
Progression of Hodgkin Lymphoma and Plasma Cell Neoplasms
-
Risks of Second Non-Breast Primaries Following Breast Cancer
-
Improving the Laboratory Evaluation of Monoclonal Gammopathies
-
How I Diagnose Mature T-Cell Proliferations by Flow Cytometry
-
Ibrutinib Plus Venetoclax for First-Line Treatment of CLL
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education